Skye Medicine

Skye Medicine (天宜康医药) was founded in March 2024, with its headquarters located in the Shanghai Free Trade Zone. It is an innovative biopharmaceutical company dedicated to the development of a new generation of efficient and accessible cellular immunotherapies. The company focuses on cutting-edge technological directions in cell therapy, hoping to continuously drive improvements in the safety, efficacy, and accessibility of cell therapy products through ongoing technological innovation.